A prospective single-center observational pilot study assessing the effects of sodium-glucose cotransporter-2 inhibitors on appetite markers in patients with Type 2 Diabetes Mellitus
Latest Information Update: 15 Oct 2021
At a glance
- Drugs Dapagliflozin (Primary) ; Empagliflozin (Primary) ; Ertugliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Oct 2021 New trial record